Structural Insights into the Binding Propensity of Human SHIP2 SH2 to Oncogenic CagA Isoforms from Helicobacter pylori

被引:4
作者
Wang, Zi [1 ,2 ]
Shan, Yubao [1 ]
Wang, Ru [1 ]
Zhou, Heng [1 ,2 ]
Hu, Rui [1 ,2 ]
Li, Ying [1 ,2 ]
Zhu, Jiang [1 ,2 ]
Yang, Yunhuang [1 ,2 ]
Liu, Maili [1 ,2 ]
机构
[1] Chinese Acad Sci, Innovat Acad Precis Measurement Sci & Technol,Wuh, Natl Ctr Magnet Resonance Wuhan,Wuhan Inst Phys &, State Key Lab Magnet Resonance & Atom Mol Phys,Ke, Wuhan 430071, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
NMR; INPPL1; SH2; domain; tyrosine phosphorylation; protein-protein interaction; DOMAIN; PHOSPHATASE; MECHANISMS; PROTEIN; KINASES;
D O I
10.3390/ijms231911299
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SHIP2 is a multi-domain inositol 5-phosphatase binding to a variety of phosphotyrosine (pY)-containing proteins through its SH2 domain, so as to regulate various cell signaling pathways by modulating the phosphatidylinositol level in the plasma membrane. Unfavorably, Helicobacter pylori can hijack SHIP2 through the CagA protein to induce gastric cell carcinogenesis. To date, the interaction between SHIP2 and CagA was not analyzed from a structural point of view. Here, the binding of SHIP2-SH2 with Tyr-phosphorylated peptides from four EPIYA motifs (A/B/C/D) in CagA was studied using NMR spectroscopy. The results showed that EPIYA-C and -D bind to a similar interface of SHIP2-SH2, including a pY-binding pocket and a hydrophobic pocket, to achieve high affinity, while EPIYA-A and -B bind to a smaller interface of SHIP2-SH2 with weak affinity. By summarizing the interface and affinity of SHIP2-SH2 for CagA EPIYA-A/B/C/D, c-MET and FcgR2B ITIM, it was proposed that, potentially, SHIP2-SH2 has a selective preference for L > I > V for the aliphatic residues at the pY+3 position in its ligand. This study reveals the rule of the ligand sequence bound by SHIP2-SH2 and the mechanism by which CagA protein hijacks SHIP2, which will help design a peptide inhibitor against SHIP2-SH2.
引用
收藏
页数:14
相关论文
共 30 条
[1]   SHIP2: A "NEW" Insulin Pathway Target for Aging Research [J].
Accardi, Giulia ;
Virruso, Claudia ;
Balistreri, Carmela Rita ;
Emanuele, Fabrizio ;
Licastro, Federico ;
Monastero, Roberto ;
Porcellini, Elisa ;
Vasto, Sonya ;
Verga, Salvatore ;
Caruso, Calogero ;
Candore, Giuseppina .
REJUVENATION RESEARCH, 2014, 17 (02) :221-225
[2]   Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and its Pathogenicity [J].
Ansari, Shamshul ;
Yamaoka, Yoshio .
TOXINS, 2019, 11 (11)
[3]   Type IV Secretion and Signal Transduction of Helicobacter pylori CagA through Interactions with Host Cell Receptors [J].
Backert, Steffen ;
Tegtmeyer, Nicole .
TOXINS, 2017, 9 (04)
[4]  
Dyson Jennifer M, 2012, Subcell Biochem, V58, P215, DOI 10.1007/978-94-007-3012-0_7
[5]  
Edimo William's Elong, 2014, Advances in Biological Regulation, V54, P142, DOI 10.1016/j.jbior.2013.09.002
[6]   Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells [J].
Fujii, Yumiko ;
Murata-Kamiya, Naoko ;
Hatakeyama, Masanori .
CANCER SCIENCE, 2020, 111 (05) :1596-1606
[7]   Oncogenic mechanisms of the Helicobacter pylori CagA protein [J].
Hatakeyama, M .
NATURE REVIEWS CANCER, 2004, 4 (09) :688-694
[8]   Differential Mechanisms for SHP2 Binding and Activation Are Exploited by Geographically Distinct Helicobacter pylori CagA Oncoproteins [J].
Hayashi, Takeru ;
Senda, Miki ;
Suzuki, Nobuhiro ;
Nishikawa, Hiroko ;
Ben, Chi ;
Tang, Chao ;
Nagase, Lisa ;
Inoue, Kaori ;
Senda, Toshiya ;
Hatakeyama, Masanori .
CELL REPORTS, 2017, 20 (12) :2876-2890
[9]   FcγRIIb-SHIP2 axis links Aβ to tau pathology by disrupting phosphoinositide metabolism in Alzheimer's disease mode [J].
Kam, Tae-In ;
Park, Hyejin ;
Gwon, Youngdae ;
Song, Sungmin ;
Kim, Seo-Hyun ;
Moon, Seo Won ;
Jo, Dong-Gyu ;
Jung, Yong-Keun .
ELIFE, 2016, 5
[10]   The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading [J].
Koch, A ;
Mancini, A ;
El Bounkari, O ;
Tamura, T .
ONCOGENE, 2005, 24 (21) :3436-3447